SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001824293-21-000009
Filing Date
2021-08-10
Accepted
2021-08-10 08:06:21
Documents
17
Period of Report
2021-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ck00018242493-20210810.htm   iXBRL 8-K 32759
2 EX-99.1 exhibit991-pressrelease.htm EX-99.1 24015
6 GRAPHIC ck00018242493-20210810_g1.jpg GRAPHIC 16879
7 GRAPHIC ck00018242493-20210810_g2.jpg GRAPHIC 1656
8 GRAPHIC ck00018242493-20210810_g3.jpg GRAPHIC 95792
9 GRAPHIC image_15a.jpg GRAPHIC 3630
  Complete submission text file 0001824293-21-000009.txt   491159

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ck00018242493-20210810.xsd EX-101.SCH 1941
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ck00018242493-20210810_lab.xml EX-101.LAB 25848
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ck00018242493-20210810_pre.xml EX-101.PRE 13598
10 EXTRACTED XBRL INSTANCE DOCUMENT ck00018242493-20210810_htm.xml XML 11695
Mailing Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103 (267) 207-3606
Vallon Pharmaceuticals, Inc. (Filer) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40034 | Film No.: 211158483
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences